Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Experts are predicting strong performance driven by the continued success of Lilly's blockbuster medications, particularly recent launches. However, there are also concerns about potential headwinds from regulato